4/21/11 Contest Update
It was a short four-day week but stocks did not come up short.
At Thursday’s close, the Nasdaq Biotech Index was up 12.65% YTD (vs. up 12.34% YTD a week ago) and the Contest median was up 10.14% YTD (vs. up 8.49% YTD a week ago). The Nasdaq Composite Index was up 6.31% YTD (vs. up 4.21% YTD a week ago).
MCBIO’s portfolio (up 39.12% YTD) picked up a few more percent and held on to the lead, but we have a new second place contender. CRAZYP’s portfolio (up 35.78% YTD) had a huge week, pushing ROCKY’s portfolio (up 33.77% YTD) back to third place.
At Thursday's close, 31 of the 38 Contest portfolios were still in the black with 16 of the 38 now beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week (foreign stock prices are not converted to US$ in these two tables).
Portfolio adjustments:
1) The GENZ CVR (GCVRZ) was added to TECHNET’s portfolio.
2) GNVC 1-10 reverse split became effective.
Happy Holidays biotechies!
(All corrections, especially adjustments for splits, greatly appreciated.)
4/21/11
Rank Name Profit/Loss
1 MCBIO 39,116
2 CRAZYP 35,775
3 ROCKY 33,771
4 RRGE 33,410
5 IJF 25,527
6 FIB 25,377
7 GENE 18,365
8 RKRW 18,101
9 GEORGIA 17,378
10 IMAN 17,148
Week's Top 5 Gainers
Symbol 4/15 4/21 % change
AMRN 8.77 16.92 92.97%
ACAD 1.77 2.24 26.55%
ANTH 5.81 6.86 18.07%
ZLCS 2.48 2.89 16.53%
GNOM 13.44 15.60 16.07%
Week's Top 5 Losers
Symbol 4/15 4/21 % change
MYG.TO 0.47 0.41 -12.90%
NRGX.OB 0.78 0.70 -10.26%
RGDX 2.29 2.06 -10.04%
VPHM 21.81 19.72 -9.58%
ROSG 0.46 0.42 -9.09% |
